ECG Interpretation: 74-Year-Old Female
This ECG shows borderline QT prolongation that warrants clinical correlation and evaluation for reversible causes, though it does not meet criteria for high-risk prolongation requiring immediate intervention.
Key ECG Parameters Analysis
Normal Findings:
- Heart rate: 65 bpm (normal sinus rhythm)
- PR interval: 144 ms (normal; upper limit 200 ms)
- QRS duration: 100 ms (normal for adults; upper limit 110 ms) 1
Borderline Finding Requiring Attention:
- QTc interval: 442-460 ms
QTc Interpretation in Context
For a 74-year-old female, this QTc falls in the borderline-to-mildly prolonged range. The normal upper limit for women is approximately 480 ms (99th percentile) 2, though values >460 ms warrant clinical attention 3. Your patient's QTc of 442-460 ms exceeds the commonly cited threshold of 440 ms but remains below the high-risk threshold of 500 ms 4, 5.
Age and Sex Considerations:
- Women have longer QTc intervals than men (approximately 10-20 ms longer) 6, 7
- QTc increases with age in both sexes, with positive correlation between advancing age and QTc prolongation 7, 8
- Normal range for women using ambulatory monitoring: 411-471 ms (2.5-97.5 percentiles) 7
Clinical Action Plan
Immediate Steps:
Review medication list thoroughly for QT-prolonging drugs:
- High-risk medications: antiarrhythmics (sotalol, amiodarone), certain antibiotics (fluoroquinolones, macrolides), antipsychotics (ziprasidone, haloperidol), antidepressants (citalopram, escitalopram)
- Check www.crediblemeds.org for comprehensive drug interactions 4
- Multiple QT-prolonging drugs together dramatically increase risk 9
Check electrolytes immediately:
Assess for bradycardia contribution:
- Heart rate of 65 bpm is appropriate, but if patient has episodes of slower rates, this could exacerbate QT prolongation
Evaluate thyroid function if not recently checked (hypothyroidism prolongs QT) 4
Risk Stratification:
Your patient is at LOW-TO-MODERATE risk because:
- QTc <500 ms (high-risk threshold not met) 4, 5
- No mention of symptoms (syncope, palpitations, seizures)
- Stable sinus rhythm at 65 bpm
Risk increases significantly if:
- QTc exceeds 500 ms 5
- QTc increases by >60 ms from baseline 3
- Multiple risk factors present: female sex, age >65, cardiovascular disease, electrolyte abnormalities, concurrent QT-prolonging medications 4, 9
Monitoring Recommendations:
- Repeat ECG if initiating any new medications, especially those with known QT effects 11
- Measure QT in lead V2 or V3 (typically shows longest QT) for serial comparisons 12
- Use same lead for all future measurements to ensure consistency 2
- If QTc approaches or exceeds 500 ms, consider cardiology referral 5
Important Caveats:
- Automated QTc calculations can be inaccurate—always verify visually, especially at heart rates outside 60-100 bpm 2
- The Bazett correction (most commonly used) overcorrects at faster heart rates and may overestimate QTc 2
- Drug-drug interactions are critical: CYP2D6 inhibitors can increase levels of other QT-prolonging drugs 9
- In elderly patients with multiple medications, seemingly "safe" drugs in combination can create significant risk 9
Bottom line: Document this borderline QTc, investigate reversible causes (medications, electrolytes), and establish baseline for future comparison. No immediate intervention required unless additional risk factors emerge.